EP3448890
BISPECIFIC ANTIBODIES TARGETING EGFR AND HER2
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.4.2017EP published:
19.7.2023EP application number:
17724504.0
EPO information:
European Patent Register
Max expiry date:
27.4.2037
Title in English:
BISPECIFIC ANTIBODIES TARGETING EGFR AND HER2Language of the patent:
English
Timeline
Today
28.4.2017EP application
19.7.2023EP Publication
Owner
Name:
Biomunex PharmaceuticalsAddress:
113 rue de la Tour, 75116 Paris, FR
Name:
INSERM (Institut National de la Santé et de la Recherche Médicale)Address:
101, rue de Tolbiac, 75013 Paris, FR
Name:
Université de MontpellierAddress:
163, rue Auguste Broussonnet, 34090 Montpellier, FR
Name:
Institut Régional du Cancer de Montpellier (ICM)Address:
208 Rue des Apothicaires Parc Euromédecine, 34298 Montpellier Cedex 5, FR
Inventor
Name:
ZHUKOVSKY, EugeneAddress:
75016 Paris, FR
Name:
LEGER, OlivierAddress:
74800 Saint Sixt, FR
Name:
GERARD, Pierre-EmmanuelAddress:
75116 Paris, FR
Name:
PELEGRIN, AndréAddress:
75013 Paris, FR
Name:
LARBOURET, ChristelAddress:
75013 Paris, FR
Priority
Number:
16305496Date:
28.4.2016Country:
EP
Classification
Categories:
C07K 16/28, C07K 16/46